Comparative Pharmacology
Head-to-head clinical analysis: FORBAXIN versus SATRIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FORBAXIN versus SATRIC.
FORBAXIN vs SATRIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FORBAXIN is a prodrug of the active moiety cefditoren, a cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
SATRIC is a combination of sulfathiazole, sulfacetamide, and sulfabenzamide, which are sulfonamide antibiotics. They competitively inhibit dihydropteroate synthase, blocking folate synthesis in susceptible bacteria.
IV: 500 mg every 12 hours, infused over 30 minutes.
No standard dosing information available for SATRIC.
None Documented
None Documented
8-12 hours; prolonged in renal impairment (up to 24 hours in severe cases)
3-5 hours in healthy adults; prolonged to 6-8 hours in renal impairment (CrCl < 30 mL/min)
Renal (60-70% unchanged), biliary/fecal (20-30%)
Renal: 70% unchanged; fecal: 20%; biliary: 10%
Category C
Category C
Antibiotic
Antiprotozoal, Antibiotic